Your browser doesn't support javascript.
loading
A longitudinal seizure outcome following the COVID-19 pandemic in 2020 and 2021: Transient exacerbation or sustainable mitigation.
Neshige, Shuichiro; Aoki, Shiro; Takebayashi, Yoshiko; Shishido, Takeo; Yamazaki, Yu; Iida, Koji; Maruyama, Hirofumi.
Afiliação
  • Neshige S; Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Graduate School of Biomedical and Health Sciences, Japan; Epilepsy Center, Hiroshima University Hospital, Japan. Electronic address: s-neshige@hiroshima-u.ac.jp.
  • Aoki S; Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Graduate School of Biomedical and Health Sciences, Japan.
  • Takebayashi Y; Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Graduate School of Biomedical and Health Sciences, Japan.
  • Shishido T; Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Graduate School of Biomedical and Health Sciences, Japan.
  • Yamazaki Y; Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Graduate School of Biomedical and Health Sciences, Japan.
  • Iida K; Epilepsy Center, Hiroshima University Hospital, Japan; Department of Neurosurgery, Hiroshima University, Graduate School of Biomedical and Health Sciences, Japan.
  • Maruyama H; Department of Clinical Neuroscience and Therapeutics, Hiroshima University, Graduate School of Biomedical and Health Sciences, Japan; Epilepsy Center, Hiroshima University Hospital, Japan.
J Neurol Sci ; 434: 120100, 2022 03 15.
Article em En | MEDLINE | ID: mdl-34952346

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Assunto principal: Epilepsia / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Adult / Humans / Middle aged Idioma: En Revista: J Neurol Sci Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Assunto principal: Epilepsia / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Adult / Humans / Middle aged Idioma: En Revista: J Neurol Sci Ano de publicação: 2022 Tipo de documento: Article